The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
Wojciechowska W, Rajzer M, Kreutz R, Weber T, Bursztyn M, Persu A, Stergiou G, Parati G, Bilo G, Pac A, Grassi G, Mancia G, Januszewicz A, Chrostowska M, Narkiewicz K, Dubiela A, Doumas M, Imprialos K, Stavropoulos K, de Freminville JB, Azizi M, Cunha PG, Lewandowski J, Strzelczyk J, Wuerzner G, Gosk-Przybyłek M, Szwench-Pietrasz E, Prejbisz A, Van der Niepen P, Kahan T, Jekell A, Spaak J, Tsioufis K, Ehret G, Doroszko A, Kubalski P, Polonia J, Styczkiewicz K, Styczkiewicz M, Mazur S, Veglio F, Rabbia F, Eula E, Águila FJ, Sarzani R, Spannella F, Jarai Z, Papadopoulos D, Lopez-Sublet M, Ostrowska A, Grassos C, Kahrimanidis I, Eugenia G, Areti T, Tomasz G, Barbara W, Aleksandra S, Beata M, Angeliki N, Robles NR, Widmiski J, Zbroch E; ESH ABPM COVID-19 Study Investigators (Excellence Centres of the European Society of Hypertension).
Wojciechowska W, et al. Among authors: narkiewicz k.
J Hypertens. 2024 Dec 1;42(12):2065-2074. doi: 10.1097/HJH.0000000000003752. Epub 2024 Sep 19.
J Hypertens. 2024.
PMID: 39248094